|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Henry Schein Inc. (HSIC) (Nasdaq:HSIC), a major distributor of healthcare products and services. |
|---|---|
| Transferring Party | W & J Dunlop Ltd, a supplier of animal health products to veterinary clinics in the U.K. |
| Sector | Distribution |
| Date | August 29, 2007 |
| Analysis Strengthens Schein's European animal health business, which will now extend to Austria, Germany, Portugal, Spain, Switzerland and the U.K., as well as the U.S. In 06 Schein bought NLS Animal Health in the U.S. and Provet in Switzerland. Terms not disclosed; Dunlop had revenue of about $300m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |